Trial
NCT06310811
Anti-CD19 CAR-T Cell Therapy in Participants With Moderate to Severe Active Systemic Lupus Erythematosus
UnknownSUSPENDEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Collaborators
—
Condition
Safety
Intervention
RD06-04 Cells injection
Why stopped
R\&D strategy adjustment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-02-03